Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Vildact M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Cognitive Life Sciences Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildact M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two active ingredients to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate the risk of severe diabetic complications, including nephropathy and vision impairment, and may lessen the likelihood of cardiovascular events. Combiflex DM 500mg/50mg may be administered as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy necessitates adherence to a balanced diet and regular physical activity. Dosage is individualized based on your specific health status, glycemic control, and concurrent medications. Ingestion with meals minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, is crucial for maximum therapeutic benefit; discontinuation should only occur under medical supervision. Maintaining blood glucose within the target range prevents future complications. Strict adherence to your prescribed diet and exercise regimen is vital. Lifestyle modifications significantly impact diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential side effect particularly when used with insulin or sulfonylureas, necessitates awareness of its symptoms and appropriate management. This medication is not universally suitable. Prior to commencement, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating treatment. Potential drug interactions necessitate comprehensive disclosure of all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to induce hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout the course of treatment.

Primary Ingredients of Vildact M 500mg/50mg Tablet

There is no text provided to rephrase.

Uses of Vildact M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vildact M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Vildact M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Vildact M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildact M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Vildact M 500mg/50mg tablets should be taken with a meal.

How Vildact M 500mg/50mg Tablet works:

Vildact M 500mg/50mg tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vildact M 500mg/50mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Vildact M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before recommending this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Vildact M 500mg/50mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vildact M 500mg/50mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely refrain from using Vildact M 500mg/50mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Vildact M 500mg/50mg Tablet :

Should you forget a Vildact M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildact M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildact M 500mg/50mg Tablet

Vildact M 500mg/50mg Tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildact M 500mg/50mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first consulting your doctor.
Patients with known allergies to Vildact M 500mg/50mg Tablet components or excipients should not use this medication. Furthermore, its use is contraindicated in individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Vildact M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin release. This combination is contraindicated for individuals under 18.
Vildact M 500mg/50mg Tablets can, rarely, cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users, thus necessitating avoidance in these groups. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue use and seek immediate medical attention.
Prolonged Vildact M 500mg/50mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildact M 500mg/50mg Tablet is safe when used as directed by your doctor. While following the prescribed dosage, you may still experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia) if also taking insulin or sulphonylurea. Report any persistent issues to your physician.
Vildact M 500mg/50mg Tabl...
162
MRP 188
13% off